147 related articles for article (PubMed ID: 17458645)
1. Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.
Hagiwara S; Iwasaka H; Noguchi T
J Anesth; 2007; 21(2):164-70. PubMed ID: 17458645
[TBL] [Abstract][Full Text] [Related]
2. Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.
Hidaka S; Iwasaka H; Hagiwara S; Noguchi T
J Surg Res; 2011 Jan; 165(1):142-50. PubMed ID: 19766246
[TBL] [Abstract][Full Text] [Related]
3. Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats.
Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K
Am J Respir Crit Care Med; 1997 Feb; 155(2):711-8. PubMed ID: 9032217
[TBL] [Abstract][Full Text] [Related]
4. Nafamostat mesilate inhibits high-mobility group box 1 by lipopolysaccharide stimulation in murine macrophage RAW 264.7.
Hagiwara S; Iwasaka H; Matumoto S; Noguchi T
Shock; 2007 Apr; 27(4):429-35. PubMed ID: 17414427
[TBL] [Abstract][Full Text] [Related]
5. Paeonol attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats.
Liu X; Xu Q; Mei L; Lei H; Wen Q; Miao J; Huang H; Chen D; Du S; Zhang S; Zhou J; Deng R; Li Y; Li C; Li H
Int Immunopharmacol; 2018 Aug; 61():169-177. PubMed ID: 29883962
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models.
Hagiwara S; Iwasaka H; Matsumoto S; Hasegawa A; Yasuda N; Noguchi T
Shock; 2010 Mar; 33(3):282-8. PubMed ID: 19536047
[TBL] [Abstract][Full Text] [Related]
7. Galantamine protects against lipopolysaccharide-induced acute lung injury in rats.
Li G; Zhou CL; Zhou QS; Zou HD
Braz J Med Biol Res; 2016 Feb; 49(2):e5008. PubMed ID: 26648090
[TBL] [Abstract][Full Text] [Related]
8. A neutrophil elastase inhibitor, sivelestat, reduces lung injury following endotoxin-induced shock in rats by inhibiting HMGB1.
Hagiwara S; Iwasaka H; Togo K; Noguchi T
Inflammation; 2008 Aug; 31(4):227-34. PubMed ID: 18536984
[TBL] [Abstract][Full Text] [Related]
9. Effects of HMGB1 on PMN apoptosis during LPS-induced acute lung injury.
Feng Y; Yang Q; Xu J; Qian G; Liu Y
Exp Mol Pathol; 2008 Dec; 85(3):214-22. PubMed ID: 18952078
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia.
Nagato M; Okamoto K; Abe Y; Higure A; Yamaguchi K
Crit Care Med; 2009 Jul; 37(7):2181-6. PubMed ID: 19487933
[TBL] [Abstract][Full Text] [Related]
11. Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release.
Liu XX; Yu DD; Chen MJ; Sun T; Li G; Huang WJ; Nie H; Wang C; Zhang YX; Gong Q; Ren BX
Int Immunopharmacol; 2015 Apr; 25(2):370-6. PubMed ID: 25724384
[TBL] [Abstract][Full Text] [Related]
12. Propofol inhibits the release of interleukin-6, 8 and tumor necrosis factor-α correlating with high-mobility group box 1 expression in lipopolysaccharides-stimulated RAW 264.7 cells.
Jia J; Sun Y; Hu Z; Li Y; Ruan X
BMC Anesthesiol; 2017 Oct; 17(1):148. PubMed ID: 29073894
[TBL] [Abstract][Full Text] [Related]
13. The prevention of lipopolysaccharide-induced pulmonary vascular injury by pretreatment with cepharanthine in rats.
Murakami K; Okajima K; Uchiba M
Am J Respir Crit Care Med; 2000 Jan; 161(1):57-63. PubMed ID: 10619798
[TBL] [Abstract][Full Text] [Related]
14. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
Luo Y; Che W; Zhao M
Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
[TBL] [Abstract][Full Text] [Related]
15. Heme oxygenase-1 upregulation significantly inhibits TNF-alpha and Hmgb1 releasing and attenuates lipopolysaccharide-induced acute lung injury in mice.
Gong Q; Yin H; Fang M; Xiang Y; Yuan CL; Zheng GY; Yang H; Xiong P; Chen G; Gong FL; Zheng F
Int Immunopharmacol; 2008 Jun; 8(6):792-8. PubMed ID: 18442782
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of recombinant thrombomodulin for lung injury after pneumonectomy via inhibition of high-mobility group box 1 in mice.
Takahashi Y; Matsutani N; Dejima H; Nakayama T; Okamura R; Uehara H; Kawamura M
J Trauma Acute Care Surg; 2016 Nov; 81(5):868-875. PubMed ID: 27504958
[TBL] [Abstract][Full Text] [Related]
17. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.
Isozaki Y; Yoshida N; Kuroda M; Handa O; Takagi T; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
Scand J Gastroenterol; 2006 Aug; 41(8):944-53. PubMed ID: 16803693
[TBL] [Abstract][Full Text] [Related]
18. Ketamine effect on HMGB1 and TLR4 expression in rats with acute lung injury.
Qin MZ; Gu QH; Tao J; Song XY; Gan GS; Luo ZB; Li BX
Int J Clin Exp Pathol; 2015; 8(10):12943-8. PubMed ID: 26722488
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with olprinone hydrochloride, a phosphodiesterase III inhibitor, attenuates lipopolysaccharide-induced lung injury via an anti-inflammatory effect.
Koike T; Nadeen Qutab M; Tsuchida M; Takekubo M; Saito M; Hayashi J
Pulm Pharmacol Ther; 2008; 21(1):166-71. PubMed ID: 17434327
[TBL] [Abstract][Full Text] [Related]
20. Filtration leukocytapheresis therapy ameliorates lipopolysaccharide-induced systemic inflammation in a rat model.
Hagiwara S; Iwasaka H; Hasegawa A; Hidaka S; Uno A; Ueo K; Uchida T; Noguchi T
J Surg Res; 2011 Dec; 171(2):777-82. PubMed ID: 20828721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
